Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples
- PMID: 16517877
- PMCID: PMC1393130
- DOI: 10.1128/JCM.44.3.923-927.2006
Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples
Abstract
Streptococcus pseudopneumoniae is a recently described streptococcus that is phenotypically and genetically distinct from Streptococcus pneumoniae and other viridans streptococci. Key characteristics of S. pseudopneumoniae are the absence of a pneumococcal capsule, insolubility in bile, resistance or indeterminate susceptibility to optochin when incubated in 5% CO2 but susceptibility to optochin when incubated in ambient air, and a positive reaction with the AccuProbe DNA probe hybridization test. The clinical importance of this bacterium is currently unknown. We report the characteristics and associated clinical data of 35 strains of S. pseudopneumoniae isolated from sputum samples from 33 patients. All isolates produced a positive result with the NOW S. pneumoniae antigen test (Binax, Inc.). No isolate was resistant to penicillin, but 60% were resistant to erythromycin and 77% were resistant to tetracycline. All patients had lower respiratory tract symptoms, 79% had chronic obstructive pulmonary disease (COPD), and 33% had chest radiographic infiltrates. Compared with matched control patients who had Streptococcus pneumoniae isolated from sputum, patients with S. pseudopneumoniae infection were more likely to have a history of COPD (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.67 to 20.11) or exacerbation of COPD (OR, 6.5; 95% CI, 2.61 to 16.20). Further research is needed to better characterize the epidemiology of S. pseudopneumoniae colonization and the role of S. pseudopneumoniae in COPD and other diseases.
Figures
Similar articles
-
Streptococcus pseudopneumoniae: an emerging respiratory tract pathogen.Indian J Med Res. 2012 Nov;136(5):877-80. Indian J Med Res. 2012. PMID: 23287138 Free PMC article.
-
Incidence and pathogenic effect of Streptococcus pseudopneumoniae.J Clin Microbiol. 2006 Jun;44(6):2240-1. doi: 10.1128/JCM.02643-05. J Clin Microbiol. 2006. PMID: 16757628 Free PMC article.
-
Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.Respirology. 2007 Jan;12(1):81-7. doi: 10.1111/j.1440-1843.2006.00999.x. Respirology. 2007. PMID: 17207030
-
Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.Clin Infect Dis. 2001 Aug 15;33(4):577-9. doi: 10.1086/321910. Epub 2001 Jul 6. Clin Infect Dis. 2001. PMID: 11462199 Review.
-
[The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].Klin Med (Mosk). 2007;85(5):10-5. Klin Med (Mosk). 2007. PMID: 17665597 Review. Russian.
Cited by
-
Use of genomics to design a diagnostic assay to discriminate between Streptococcus pneumoniae and Streptococcus pseudopneumoniae.Microb Genom. 2018 Jul;4(7):e000175. doi: 10.1099/mgen.0.000175. Epub 2018 Apr 9. Microb Genom. 2018. PMID: 29629856 Free PMC article.
-
Competitive advantage of oral streptococci for colonization of the middle ear mucosa.Biofilm. 2022 Jan 18;4:100067. doi: 10.1016/j.bioflm.2022.100067. eCollection 2022 Dec. Biofilm. 2022. PMID: 35146417 Free PMC article.
-
Inhibitory effect of streptococci on the growth of M. catarrhalis strains and the diversity of putative bacteriocin-like gene loci in the genomes of S. pneumoniae and its relatives.AMB Express. 2017 Dec 13;7(1):218. doi: 10.1186/s13568-017-0521-z. AMB Express. 2017. PMID: 29236192 Free PMC article.
-
Characterization and comparison of bacterial communities in benign vocal fold lesions.Microbiome. 2014 Dec 8;2:43. doi: 10.1186/2049-2618-2-43. eCollection 2014. Microbiome. 2014. PMID: 25671105 Free PMC article.
-
Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.Infection. 2020 Feb;48(1):19-35. doi: 10.1007/s15010-019-01350-1. Epub 2019 Sep 3. Infection. 2020. PMID: 31482316
References
-
- Arbique, J. C., C. Poyart, P. Trieu-Cuot, G. Quesne, M. da Glória, S. Carvalho, A. G. Steigerwalt, R. E. Morey, D. Jackson, R. J. Davidson, and R. R. Facklam. 2004. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J. Clin. Microbiol. 42:4686-4696. - PMC - PubMed
-
- Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. CLSI, Wayne, Pa.
-
- Cochetti, I., M. Vecchi, M. Mingoia, E. Tili, M. R. Catania, A. Manzin, P. E. Varaldo, and M. P. Montanari. 2005. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I). Antimicrob. Agents Chemother. 49:4999-5006. - PMC - PubMed
-
- Euzéby, J. 2005. Validation of publication of new names and new combinations previously effectively published outside the IJSEM. Int. J. Syst. Evol. Microbiol. 55:1-2. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases